🇺🇸 Intralipid, 20% Intravenous in United States

Intralipid, 20% Intravenous (Intralipid, 20% Intravenous) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intralipid, 20% Intravenous in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intralipid, 20% Intravenous approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intralipid, 20% Intravenous in United States?

Hospital for Special Surgery, New York is the originator. The local marketing authorisation holder may differ — check the official source linked above.